Affimed N.V. (AFMD) earnings
Quarterly and annual AFMD reports and results, each read against the price at its own news timestamp. Back to the AFMD overview →
8 measured AFMD earnings events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Affimed Reports Third Quarter 2024 Financial Results & Business Update | Press release | +2.39% | -2.93% | |
| Affimed to Report Third Quarter 2024 Financial Results & Corporate Update on November 14, 2024 | Press release | +0.00% | -4.80% | |
| Affimed Reports Second Quarter 2024 Financial Results & Business Update | Press release | -4.07% | -3.56% | |
| Affimed to Report Second Quarter 2024 Financial Results & Corporate Update on September 5, 2024 | Press release | +0.00% | +6.25% | |
| Affimed Reports First Quarter 2024 Financial Results & Business Update | Press release | +0.54% | -1.72% | |
| Affimed to Report First Quarter 2024 Financial Results & Corporate Update on June 12, 2024 | Press release | -1.00% | -5.31% | |
| Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress | Press release | -0.58% | -3.79% | |
| Affimed to Report Third Quarter 2023 Financial Results & Corporate Update on November 14, 2023 | Press release | -2.46% | -7.34% |
Keep exploring
More AFMD: analyst actions → · SEC filings → · AFMD overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Genetic Technologies Ltd - American Depositary Shares (GENE) | 79 | -0.05% | 33% |
| MOTIF BIO PLC ADRS (MTFB) | 79 | 0.00% | 39% |
| Gamida Cell Ltd. - Ordinary Shares (GMDA) | 78 | -2.45% | 28% |
| GROW SOLUTIONS HLDGS (GRSO) | 78 | 0.00% | 40% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.